The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
Số trang: 12
Loại file: pdf
Dung lượng: 1.58 MB
Lượt xem: 12
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Aberrant methylation of EphA7 has been reported in the process of carcinogenesis but not in cervical cancer. Therefore, an integration study was performed to explore the association between EphA7 hypermethylation and cervical cancer and validate the potential value of EphA7 hypermethylation in the diagnosis of cervical cancer.
Nội dung trích xuất từ tài liệu:
The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
Nội dung trích xuất từ tài liệu:
The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
Tìm kiếm theo từ khóa liên quan:
BMC Cancer DNA methylation Cervical cancer Aberrant methylation EphA7 hypermethylationTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
13 trang 38 0 0